Copyright
©The Author(s) 2021.
World J Diabetes. Apr 15, 2021; 12(4): 306-330
Published online Apr 15, 2021. doi: 10.4239/wjd.v12.i4.306
Published online Apr 15, 2021. doi: 10.4239/wjd.v12.i4.306
Hurdles in clinical islet transplantation for type 1 diabetes mellitus | |
1 | Poor access to human islets due to the scarcity of organ donors |
2 | Graft failure (e.g., metabolic pressure, oxidative stress caused by hypoxia or inflammation) |
3 | Continued autoimmunity and alloimmunity |
4 | Immunosuppressive drug therapy |
5 | Behavior of the transplanted cells in the growing body for transplantations performed in adolescents/children |
Advantages | |
1 | Similar body size, shape, and anatomy as that of humans |
2 | Human-relevant metabolic physiology and pathophysiology |
3 | Monogastric omnivore |
4 | Multiparity, short gestation, short generation interval, and long-life cycle |
5 | Pancreatic and islet architecture similar to that of humans |
6 | Can undergo the same surgical procedure as in humans |
7 | Tools for genetic alterations are available |
8 | High litter size makes the production of genetically modified pigs less time-consuming in comparison with other livestock species |
Disadvantages | |
1 | Specialized facilities are required |
2 | Costly to maintain |
3 | Ethical issues associated with the use of pigs in biomedical research |
- Citation: Nagaya M, Hasegawa K, Uchikura A, Nakano K, Watanabe M, Umeyama K, Matsunari H, Osafune K, Kobayashi E, Nakauchi H, Nagashima H. Feasibility of large experimental animal models in testing novel therapeutic strategies for diabetes. World J Diabetes 2021; 12(4): 306-330
- URL: https://www.wjgnet.com/1948-9358/full/v12/i4/306.htm
- DOI: https://dx.doi.org/10.4239/wjd.v12.i4.306